Figure 3 | British Journal of Cancer

Figure 3

From: An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma

Figure 3

Roscovitine sensitises MPM cells to cisplatin. (A) MPM cell lines were treated with increasing concentrations of Roscovitine, INH1 or BI 2536 and cytotoxic effects were determined at 96 h. (B) MPM cell lines were treated with increasing concentrations of cisplatin together with the indicated concentration of Roscovitine and INH1 and cytotoxic effects were determined at 96 h.

Back to article page